tech
Why Biopharma Can’t Afford Pre‑COVID Hiring Models Anymore
When the pandemic forced labs to go quiet, the industry discovered a surprising truth: talent doesn’t stay put when flexibility disappears. In 2024, CEOs and talent leaders are watching a quiet exodus of high-performing scientists who choose hybrid-friendly rivals over legacy hiring playbooks. The data is stark, the stories